Agenus

AGEN51

Penny Stock

$3.03arrow_drop_down2.41%-$0.07

Penny Stock

AGEN51

$3.03

arrow_drop_down2.41%-$0.07

Penny Stock

Performance History

Key Stats
Open	$3.60
Prev. Close	$3.90
EPS	-11.14
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$67.95M
PE Ratio	-

	LOW	HIGH
Day Range	2.98	5.45
52 Week Range	2.98	23.20

Ratios

Revenue	-





EPS	-11.14

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Agenus (AGEN)

Agenus Inc. (AGEN) is a biotechnology company focused on developing innovative immuno-oncology treatments. The company's stock price history shows a volatile performance over the years, with fluctuations driven by market conditions, drug pipeline updates, and clinical trial results. Investors should carefully analyze these factors when considering an investment in Agenus Inc. The stock is currently trading at $3.50 per share.

The company's latest quote indicates that Agenus Inc. stock is trending positively. Analysts have a positive outlook on the company's prospects, citing its strong pipeline and collaborations with other leading biopharmaceutical companies. Agenus Inc. continues to make headlines with exciting news related to its innovative immuno-oncology treatments.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Headquarters: Lexington
Employees: 533
Exchange: NASDAQ

Keep an eye on Agenus

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Agenus 's (AGEN) price per share?

The current price per share for Agenus (AGEN) is $3.03. The stock has seen a price change of -$0.08 recently, indicating a -2.42% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Agenus (AGEN)?

For Agenus (AGEN), the 52-week high is $23.2, which is 665.68% from the current price. The 52-week low is $2.98, the current price is 1.51% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Agenus (AGEN) a growth stock?

Agenus (AGEN) has shown an average price growth of -3.13% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Agenus as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Agenus (AGEN) stock price performance year to date (YTD)?

As of the latest data, Agenus (AGEN) has a year-to-date price change of -81.07%. Over the past month, the stock has experienced a price change of -35.94%. Over the last three months, the change has been -35.67%. Over the past six months, the figure is -72.68%. Looking at a longer horizon, the five-year price change stands at -95.98%.

help

Is Agenus (AGEN) a profitable company?

Agenus (AGEN) has a net income of -$245.76M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 89.32% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -128.43% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 59.47%, providing insight into the company's sales performance and growth. The gross profit is $139.62M. Operating income is noted at -$160.1M. Furthermore, the EBITDA is -$85.51M.

help

What is the market capitalization of Agenus (AGEN)?

Agenus (AGEN) has a market capitalization of $65.36M. The average daily trading volume is 3.11, indicating the stock's liquidity and investor engagement.